Valerie Wilson
Nurse Practitioner · Bowling Green, KYNPI 1114567047
Payments from drug & device makers
Across 235 payments — averaging $14.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$861
- AbbVie$716
- Phathom Pharmaceuticals, Inc.$309
- Johnson & Johnson$203
- Grifols USA, LLC$176
- Ironwood Pharmaceuticals, Inc$121
- plus $934 from 25 others
What the payments were for
- Food & beverage$3,18596%
- Education$1364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$118
How this compares
$3,321 in reported general payments places this provider in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 76 | $70,374 |
| XifaxanRifaximin | 21 | $66,622 |
| RelistorMethylnaltrexone Bromide | 16 | $62,867 |
| TrulancePlecanatide | 30 | $30,647 |
| CreonLipase/Protease/Amylase | 19 | $28,673 |
| Dexlansoprazole DrDexlansoprazole | 56 | $22,782 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 319 | $20,496 |
| VoqueznaVonoprazan Fumarate | 29 | $20,178 |
| MovantikNaloxegol Oxalate | 32 | $18,122 |
| MotegrityPrucalopride Succinate | 12 | $18,058 |
| Mesalamine | 17 | $11,311 |
| Mesalamine ErMesalamine | 25 | $6,963 |
| Sucralfate | 50 | $6,811 |
| Pantoprazole Sodium | 685 | $6,311 |
| Ursodiol | 23 | $4,933 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Relistor, Trulance | $861 | $160,13667 claims |
| AbbVieLinzess, Creon | $716 | $99,04795 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $309 | $20,17829 claims |
| Redhill Biopharma Inc.Movantik | $43 | $18,12232 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Bowling Green
- Derrick ScogginsBowling Green$25K
- Emily LangloisBowling Green$10K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.